MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 194 filers reported holding MEDICINES CO in Q4 2018. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $12,907,000 | +85.9% | 151,950 | +9.4% | 0.01% | +85.7% |
| Q3 2019 | $6,943,000 | +38.6% | 138,850 | +1.1% | 0.01% | +40.0% |
| Q2 2019 | $5,009,000 | +33.1% | 137,350 | +2.0% | 0.01% | +25.0% |
| Q1 2019 | $3,763,000 | +50.7% | 134,650 | +3.2% | 0.00% | +33.3% |
| Q4 2018 | $2,497,000 | -35.0% | 130,450 | +1.6% | 0.00% | -25.0% |
| Q3 2018 | $3,839,000 | -17.3% | 128,350 | +1.4% | 0.00% | -20.0% |
| Q2 2018 | $4,644,000 | +11.4% | 126,550 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $4,169,000 | +23.3% | 126,550 | +2.3% | 0.01% | +25.0% |
| Q4 2017 | $3,381,000 | -24.3% | 123,650 | +2.5% | 0.00% | -20.0% |
| Q3 2017 | $4,469,000 | -1.0% | 120,650 | +1.6% | 0.01% | 0.0% |
| Q2 2017 | $4,514,000 | -20.9% | 118,750 | +1.8% | 0.01% | -28.6% |
| Q1 2017 | $5,704,000 | +45.0% | 116,650 | +0.6% | 0.01% | +16.7% |
| Q4 2016 | $3,935,000 | -7.0% | 115,950 | +3.5% | 0.01% | -14.3% |
| Q3 2016 | $4,229,000 | +8.7% | 112,050 | -3.1% | 0.01% | +16.7% |
| Q2 2016 | $3,889,000 | +9.6% | 115,650 | 0.0% | 0.01% | -14.3% |
| Q1 2016 | $3,547,000 | +6.8% | 115,650 | +30.1% | 0.01% | -12.5% |
| Q4 2015 | $3,320,000 | -1.6% | 88,900 | 0.0% | 0.01% | -11.1% |
| Q3 2015 | $3,375,000 | +53.0% | 88,900 | +15.3% | 0.01% | +50.0% |
| Q2 2015 | $2,206,000 | +11.5% | 77,100 | +9.2% | 0.01% | +20.0% |
| Q1 2015 | $1,978,000 | +2.7% | 70,600 | +1.4% | 0.01% | -28.6% |
| Q4 2014 | $1,926,000 | +27.3% | 69,600 | +2.7% | 0.01% | +16.7% |
| Q3 2014 | $1,513,000 | -24.1% | 67,800 | -1.2% | 0.01% | -14.3% |
| Q2 2014 | $1,994,000 | +2.3% | 68,600 | 0.0% | 0.01% | -12.5% |
| Q1 2014 | $1,950,000 | -2.0% | 68,600 | +33.2% | 0.01% | 0.0% |
| Q4 2013 | $1,989,000 | +15.2% | 51,500 | 0.0% | 0.01% | +14.3% |
| Q3 2013 | $1,726,000 | +14.8% | 51,500 | +5.3% | 0.01% | 0.0% |
| Q2 2013 | $1,504,000 | – | 48,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |